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CD4+/CD8+ T lymphocytes imbalance in children 
with severe 2009 pandemic influenza A (H1N1) 
pneumonia
Purpose: This study was conducted to investigate the immune 
responses of children with moderate and severe novel influenza A 
virus (H1N1) pneumonia, and to compare their clinical and immu-
nological findings with those of control subjects. 
Methods: Thirty-two admitted patients with H1N1 pneumonia were 
enrolled in the study. The clinical profiles, humoral and cell-mediated 
im  mune responses of the 16 H1N1 pneumonia patients who were ad-
mitted to the pediatric intensive care unit (severe pneumonia group), 
16 H1N1 pneumonia patients admitted to the pediatric general ward 
(moderate pneumonia group) and 13 control subjects (control group) 
were measured. 
Results: Total lymphocyte counts were significantly lower in patients 
with H1N1 pneumonia than in the control group (P=0.02). The num-
ber of CD4+ T lymphocytes was significantly lower in the severe 
pneumonia group (411.5±253.5/μL) than in the moderate pneumonia 
(644.9±291.1/μL, P=0.04) and control (902.5±461.2/μL, P=0.01) groups. 
However, the number of CD8+ T lymphocytes was significantly higher 
in the severe pneumonia group (684.2±420.8/μL) than in the moderate 
pneumonia (319.7±176.6/μL, P=0.02) and control (407.2±309.3/μL, 
P=0.03) groups. The CD4+/CD8+ T lymphocytes ratio was significantly 
lower in the severe pneumonia group (0.86±0.24) than in the moderate 
pneumonia (1.57±0.41, P=0.01) and control (1.61±0.49, P=0.01) groups. 
The serum levels of immunoglobulin G, immunoglobulin M and 
immunoglobulin E were significantly higher in the severe pneumonia 
group than in the 2 other groups. 
Conclusion: The results of this study suggest that increased humoral 
immune responses and the differences in the CD4+ and CD8+ T 
lymphocyte profiles, and imbalance of their ratios may be related to 
the severity of H1N1 pneumonia in children. 
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Introduction
In March 2009, a novel influenza A virus (H1N1) emerged and 
spread worldwide to cause the first pandemic of the 21st century as 
declared by the World Health Organization on June 11, 2009
1). 
Although most subjects with H1N1 infection present flu-like 
symptoms with a benign clinical course, some patients may have a 
serious respiratory illness, including pneumonia as well as respiratory 
distress, which may require mechanical ventilation
2-4). Previous 
studies have reported that more than 30% of H1N1 infected children 
were admitted to the pediatric intensive care unit (PICU) due to 
severe pneumonia
2, 5). However, immune responses associated with 
severe H1N1 pneumonia remain to be determined. Such knowledge 
of immune responses associated with severe H1N1 pneumonia may 
help clinicians identify patients and provide appropriate management. 
There are few reports on the immune responses of patients with 
H1N1 infection
6, 7). T lymphocyte function is critical to the clearance 
of influenza virus infection. Activation of CD8+ T lymphocytes 
begins to appear 3 days after infection and peaks on days 6 to 9 
during the course of influenza infection
8). Previous studies have 
revealed that CD8+T lymphocytes play a crucial role in H1N1 
infection as well as seasonal influenza virus infection
9-11). CD8+ T 
cells are important in the antiviral response to influenza via direct lysis 
or by the induction of inflammatory cytokines but they can show 
altered immune response to severe infections
8). However, immune 
responses leading to increased severity in previously healthy children 
during the course of H1N1 pneumonia are not well understood. 
This study was conducted to investigate the clinical and immu-
nological manifestations of children with moderate and severe H1N1 
pneumonia and to compare their clinical and immunologic findings 
with control subjects. 
Materials and methods
A total of 68 patients with H1N1 infection that were admitted to 
Korea University Anam Hospital between October 2009 and March 
2010 were recruited for this study. Among them, 16 patients were 
admitted to the PICU because of severe pneumonia and respiratory 
distress (severe pneumonia group). Subjects admitted to the PICU 
were described as having dyspnea and hypoxemia (oxygen saturation 
<93% in room air) or respiratory failure requiring mechanical 
ventilation. Among the 52 remaining patients with H1N1 infection 
those who were admitted to the general ward, patients with croup, 
bronchitis or neurologic diseases were excluded. Children who did 
not agree with the participation of the clinical trial were also excluded. 
Finally, 16 patients with H1N1 pneumonia that were admitted to 
the general ward were designated as having moderate pneumonia. 
Thirteen children that were admitted to the Department of Pediatrics 
for non-infectious diseases served as control subjects; some had a past 
history of recurrent infection but no identifiable airway infection 
for 4 weeks prior to this study. Nasopharyngeal real-time reverse-
transcriptase polymerase-chain-reaction (RT-PCR) was negative for 
respiratory viruses in all control subjects.
All parents of the patients and of the control subjects provided 
written informed consent for their children to participate in this 
study. The study protocol was approved by the Institutional Review 
Board of our hospital.
A complete history, a physical examination, and routine blood tests 
were performed on each subject at the time of study entry. H1N1 
infection was confirmed by nasopharyngeal swab specimens using 
RT-PCR assay at the Department of Clinical Laboratory in our 
hospital according to the manufacturer’s instructions. In addition, 
nasopharyngeal aspirates were tested to identify respiratory syncytial 
virus, adenovirus and parainfluenza virus by cultures. The diagnosis 
of pneumonia was based on clinical (fever, cough, dyspnea and 
crackles) and radiological (chest infiltrates) criteria
12). Children with 
immune disorder, neurological disease, chronic lung disease, and co-
infection by either viruses or bacteria were excluded from the study. 
Peripheral blood T lymphocyte subsets were determined with 
a BD TriTEST kit (BD Immunocytometry Systems, San Jose, 
CA, USA). CD4 fluorescein isothiocyanate, CD8 phecoery  thin, 
and CD3 peridinin chlorophyll protein were used for immu-
nofluorescence reagents. Optimal conditions for monoclonal-
antibody concentrations and incubation periods were established 
according to the manufacturer’s instructions. Fluorocytometry was 
performed with a FACSCalibur (BD Immunocytometry Systems) 
equipped with a 488-nm blue laser and a 635-nm red diode laser 
for multicolor fluorescence, in addition to forward-scatter and side-
scatter measurements. All fluorocytometric data were subsequently 
analyzed and displayed graphically using CellQuest Pro software (BD 
Immunocytometry Systems). The serum levels of immunoglobulin 
G (IgG), immunoglobulin M (IgM), and immunoglobulin A (IgA)
were measured by immunoturbidimetry (Turbiquant IgG, IgM, 
and IgA; Behringwerke AG, Marburg, Germany). Serum total 
IgE levels were measured using a Coat-A-Count Total IgE IRMA 
(Diagnostic Products Co., Los Angeles, CA, USA) according to the 
manufacturer’s instructions.
Data are presented as mean±SD. Becuase most of the data were 
not normally distributed, non-parametric analysis was used. The data 
were screened for differences in humoral immune responses and T 
lymphocyte profiles in the 3 study groups using the Kruskal-Wallis 
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were compared using the Mann-Whitney U test. All statistical 
analyses were performed using the SPSS statistical package (SPSS 
Inc., Chicago, IL, USA). A P value of less than 0.05 was considered 
statistically significant.
Results
The clinical characteristics of the children in the 3 groups are 
summarized in Tables 1 and 2. There were no significant differences 
in age and sex ratio between the 3 groups. The duration of fever was 
significantly longer, and the use of mechanical ventilation and a past 
history of asthma were more common in the severe pneumonia group 
than in the moderate pneumonia and control groups. 
Table 3 shows the humoral immune responses of the children 
in the 3 groups. The mean(±SD) serum IgG level was significantly 
higher in the severe pneumonia group (1,843.0±947.3 mg/dL) than 
in the moderate pneumonia (1,068.4±251.3 mg/dL, P=0.03) and 
control (1,146.8±474.6 mg/dL, P=0.04) groups. The mean(±SD) 
serum IgM level was also significantly higher in the severe pneumonia 
group (142.7±37.4 mg/dL) than in the moderate pneumonia 
(96.1±18.0 mg/dL, P=0.04) and control (101.0±26.0 mg/dL, P=0.04) 
groups. The severe pneumonia group showed a significantly higher 
serum total IgE level (792.3±503.4 IU/mL) than the moderate 
pneumonia (286.1±88.9 IU/mL) and control groups (145.1±89.1 IU/
mL, P=0.02). There were no significant differences in serum levels of 
IgA, C3, C4 and CH50 between the 3 groups. 
The mean(±SD) total lymphocyte counts in peripheral blood were 
significantly lower in the severe pneumonia (1,567.6±926.2/μL) and 
moderate pneumonia (1,425.6±821.4/μL) groups than in the control 
group (2,529.4±1,368.7/μL, P=0.03 and P=0.01, respectively). The 
lymphocyte subsets of the 3 groups are shown in Table 4. Children 
in the severe pneumonia group had a significantly lower number 
of CD4+ T lymphocytes (411.5±253.5/μL) than those in the 
Table 1. Clinical Characteristics of the Severe Pneumonia, Moderate 
Pneumonia and Control Groups
Group
Severe 
pneumonia  
(n=16)
Moderate 
pneumonia
(n=16)
Control 
(n=13)
Age (yr) 7.1±2.7 8.0±3.5 8.9±4.5
Female 5 (31.3) 8 (50.0) 7 (53.8)
Duration of fever (day)    4.7±2.12*  2.7±0.72 -
Cough 16 (100) 13 (81.6) 0 (0)
Dyspnea 14 (87.5)* 2 (12.5) 0 (0)
Wheezing 11 (68.8)* 1 (6.3) 0 (0)
Secondary bacterial infection 2 (12.5) 0 (0) 0 (0)
Past history of asthma 6 (37.5)* 2 (12.5) 0 (0)
Values are presented as mean±SD or number (%).
*P<0.05 compared with the moderate H1N1 pneumonia and control groups.
Table 2. Clinical and Laboratory Findings of the Severe Pneumonia and 
Moderate Pneumonia Groups
Group
Severe 
pneumonia 
(n=16)
Moderate 
pneumonia 
(n=16)
Clinical findings
Oxygen supplementation 16 (100)* 2 (12.5)
Use of mechanical ventilation    2 (12.5)* 0 (0)
Use of corticosteroids    7 (43.8)* 1 (6.3)
Laboratory findings
Aspartate aminotransferase (IU/L) 28.3±12.34 29.8±11.98
Alanine aminotransferase (IU/L) 17.2±7.36 17.7±6.36
C-reactive protein (mg/L) 42.3±36.23* 29.7±31.05
Infiltrations on chest radiography  16 (100) 7 (43.8)
Values are presented as number (%) or mean±SD.
*P<0.05 compared with the moderate H1N1 pneumonia group.
Table 3. Humoral Immune Responses of the Severe Pneumonia, 
Moderate Pneumonia and Control Groups
Parameter
Group
Severe 
pneumonia 
(n=16)
Moderate 
pneumonia 
(n=16)
Control 
(n=13)
IgG (mg/dL) 1,843.0±947.3*
† 1,068.4±251.3 1,146.8±474.6
IgM (mg/dL) 142.7±37.4*
† 96.1±18.0 101.0±26.0
IgA (mg/dL) 122.7±42.2 132.5±30.4 151.3±51.5
IgE (IU/mL) 792.3±503.4* 286.1±88.9 145.1±89.1
C3 (mg/dL) 109.2±30.5 126.3±20.0 114.1±15.1
C4 (mg/dL) 18.9±8.3 24.3±8.5 26.7±4.7
CH50 (mg/dL) 46.7±12.1 51.8±14.2 40.5±8.4
Values are presented as mean±SD.
IgG, immunoglobulin G; IgM, immunoglobulin M; IgA, immunoglobulin A; IgE, 
immunoglobulin E.
*P<0.05 compared with the control group. 
†P<0.05 compared with the 
moderate H1N1 pneumonia group.
Table 4. Peripheral Blood Lymphocyte Subset Profiles of the Severe 
Pneumonia, Moderate Pneumonia and Control Groups
Group
Severe
pneumonia 
(n=16)
Moderate 
pneumonia 
(n=16)
Control 
(n=13)
Lymphocyte (/µL) 1,567.6±926.2* 1,425.6±821.4* 2,529.4±1,368.7
CD4+ T lymphocyte (/µL) 411.5±253.5*
† 644.9±291.1* 902.5±461.2
CD8+ T lymphocyte (/µL) 684.2±420.8*
† 319.7±176.6 407.2±309.3
CD4+ / CD8+    0.86±0.24*
†   1.57±0.41   1.61±0.49
Values are presented as mean±SD.
*P<0.05 compared with the control group. 
†P<0.05 compared with the 
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children with moderate pneumonia (644.9±291.1/μL, P=0.02) and 
control (902.5±461.2/μL, P=0.01) groups. The number of CD8+ T 
lymphocytes was significantly higher in the severe pneumonia group 
(684.2±420.8/μL) than in the moderate pneumonia (319.7±176.6/
μL, P=0.02) and control (407.2±309.3/μL, P=0.03) groups. The 
ratio of CD4+/CD8+ T lymphocytes was significantly decreased 
in the severe pneumonia group (0.86±0.24) than in the moderate 
pneumonia (1.57±0.41, P=0.01) and control (1.61±0.49, P=0.01) 
groups (Fig. 1).  
Discussion
The results of this study showed that patients with severe H1N1 
pneumonia had prolonged fever, respiratory difficulties, decreased 
CD4+ T lymphocytes, increased CD8+ T lymphocytes and caused 
an imbalance of the CD4+/CD8+ T lymphocytes ratio during the 
course of infection. This is the first study to investigate the humoral 
and cellular immune responses of children with H1N1 pneumonia. 
Thirty-two children with confirmed H1N1 pneumonia were 
enrolled in this study, including 16 patients admitted to the PICU. 
The patients with severe pneumonia had dyspnea, hypoxemia or 
respiratory difficulties; however, there were no deaths.
In this study, patients with H1N1 pneumonia showed decreased 
lymphocyte counts compared to the controls, which is consistent 
with the results of previous studies
4, 6). This finding suggests that 
the H1N1 virus is capable of inhibiting cellular immune function 
and is probably related to the induction of excessive apoptosis of 
lymphocytes
13). Cellular immune responses to influenza, such as viral 
clearance
8) and lymphopenia, are related to poor prognoses in patients 
with viral infections
6, 14, 15).
Many studies have demonstrated a major role for CD8+ T 
lymphocytes in the control of viral infections
7, 10, 16). CD8+ T lym-
phocytes have either beneficial or harmful effects on the virus infected 
host. CD8+ T lymphocyte function is critical for the resolution of 
respiratory viral infections; however, it has been demonstrated that 
T lymphocyte responses to the infected respiratory epithelium may 
result in significant tissue damage
10). Subbarao et al.
8) have reported 
that the activation of CD8+ T lymphocytes begins to appear 3 days 
after infection and peaks on days 6 to 9 during the course of influenza 
infection. The increase of the CD8+ T lymphocyte response to 
H1N1 might also lead to severe infections as shown in influenza virus 
infections. 
Since replication of influenza viruses is restricted to the epithelial 
cells of the respiratory tract and systemic exposure of the immune 
system to influenza viruses is consequently limited, the contribution 
of CD8+ T lymphocytes to primary antiviral responses is not clear
17). 
However, many studies have demonstrated a crucial role of CD8+ T 
lymphocytes in the clearance of infected viruses. In our study, it was 
found that the number of CD8+ T lymphocytes was higher in the 
severe pneumonia group than in the moderate pneumonia or control 
groups. 
The CD4+/CD8+ T lymphocyte ratio was significantly de-
creased in the severe pneumonia group compared to the moderate 
pneumonia and control groups. Furthermore, the ratio of lym-
phocyte subpopulations in the moderate pneumonia group was 
within the normal range of children of the same age group reported 
by Robinson et al
18). However, it was significantly decreased in the 
severe pneumonia group. These results suggest that altered immune 
responses with increased CD8+ T lymphocyte production or 
imbalance of the CD4+ and CD8+ T lymphocytes might be related 
to severe clinical inflammatory responses to H1N1 infection. It is 
unclear whether this event is temporary or permanent because the 
number of lymphocytes was not measured after recovery from H1N1 
infection. However, this is the first demonstration of systemically 
altered CD4+/CD8+ T lymphocyte responses in children with severe 
H1N1 pneumonia. 
In this study, the serum levels of IgG and IgM were higher in 
the severe pneumonia group than in the moderate pneumonia and 
control groups. Although the increased IgM titer is suggestive of 
a recent infection, it is not certain whether it was H1N1-specific 
antibody. 
Another point to discuss is the relationship between asthma and 
Fig. 1. The CD4+/CD8+ T lymphocyte ratio is lower in children with the 
severe pneumonia than those of the moderate pneumonia and control 
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the development of severe H1N1 infection
19). In the subjects of this 
study, although there were no patients with current asthma, a past 
history of asthma was more common in the severe H1N1 pneumonia 
group (n=6, 37.5%) than in the moderate H1N1 pneumonia group 
(n=2, 12.5%, P=0.01). There were no patients with a past history of 
asthma among the control subjects. 
One of the limitations of this study is the time point at which 
measurements were made. The number of CD+ T lymphocytes 
may differ according to the amount of time elapsed since H1N1 
infection
8). In this study, lymphocyte counts were performed on 
admission, and we could not monitor the counts until they recovered 
to the normal range. In addition, some subjects in the control group 
had a history of recurrent infections; however, none of them were 
within the 4 weeks to the study. 
The inappropriate CD4+/CD8+ T lymphocyte responses and 
humoral immunity are likely to intensify the pathological process
10). 
Evaluation of immune responses including CD4+ and CD8+ 
T lymphocytes in patients with H1N1 infection will provide 
information that can aid in the development of appropriate strategies 
for the management of patients with this infection.
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